NAD, Precision Health & the Science of Living Better for Longer with Dr Jin-Xiong She

NAD, Precision Health & the Science of Living Better for Longer with Dr Jin-Xiong She

In this episode, Dr Jin-Xiong She, a scientist with more than 400 publications, over 20,000 citations, and more than $100 million in research funding, explains why he left the top tier of academic medicine to pursue something more urgent: finding better ways to detect decline early and protect healthspan before disease takes hold. He shares what nearly 100,000 NAD tests have uncovered and why he believes biomarker baselines could change the way we think about prevention.

https://www.jinfiniti.com/

https://www.youtube.com/@ProfJinShe

In this episode:

00:00 Welcome and Guest Intro

01:47 From Genomics to Longevity

04:18 T1D TEDDY Study Breakthroughs

06:07 Leaving Academia for Impact

07:37 Healthspan Over Lifespan

10:09 TAO Test Act Optimise

13:20 Choosing Actionable Biomarkers

17:02 Why NAD Tops the List

21:45 NAD Decline and Key Drivers

25:21 Raising NAD Lifestyle vs Supplements

27:51 Athletes' Inflammation and Low NAD

31:54 Optimal NAD Range and Niacin Risks

37:28 SubQ Injections vs Oral NMN Data

41:42 Dosing and Cutting Useless Supplements

43:52 Access Economics and Policy Ideas

46:50 Industry Adoption and Big Names

47:59 Supplement Market Problems

50:17 Rapid Fire and Closing Takeaways

52:04 Final Summary and Goodbye

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(32)

Can One Drug Slow Ageing Across the Whole Body? LinkGevity’s Bid to Block Necrosis

Can One Drug Slow Ageing Across the Whole Body? LinkGevity’s Bid to Block Necrosis

What if heart disease, kidney disease and dementia share a common mechanism linked to ageing? And what if blocking a destructive form of cell death called necrosis could help protect several organs at...

16 Aug 1h 6min

How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

At 39, Leslie Kenny was diagnosed with rheumatoid arthritis and lupus and says she was told she had around five years to live. More than two decades later, she is in long-term remission and has turned...

9 Aug 59min

The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

Nearly two decades ago, Dr Gil Blander was trying to convince investors of an idea that, at the time, sounded radical: blood biomarkers should not only be used to diagnose disease, but to help healthy...

2 Aug 48min

Longevity Medicine Beyond ‘Failure-Based’ Healthcare with Dr Peter Scriven

Longevity Medicine Beyond ‘Failure-Based’ Healthcare with Dr Peter Scriven

In this episode of Beyond Longevity, Daphna speaks with Dr Peter Scriven, Co-Founder and Clinical & Scientific Director of LONGEVITY, about what longevity medicine should actually look like: moving fr...

26 Jul 1h 2min

Longevity at HLTH Why Healthy Ageing Is Finally Going Mainstream

Longevity at HLTH Why Healthy Ageing Is Finally Going Mainstream

In this episode of Beyond Longevity, Daphna speaks with Jody Tropeano Greene, Head of Content at HLTH, and Alexa Mikhail, Senior Content Lead at HLTH US, about how HLTH identifies the healthcare topic...

19 Jul 52min

From Blockbuster Medicine to Extending Healthspan with Sundeep Dugar PhD

From Blockbuster Medicine to Extending Healthspan with Sundeep Dugar PhD

On Beyond Longevity, host Daphna speaks with Dr Sundeep Dugar, PhD, co-founder of BlueOakNx and the scientists behind the blockbuster cholesterol medicines Zetia (ezetimibe) and Vytorin. He explains h...

12 Jul 59min

Robert Gielow on Longevity Products, Pharmacy Access and Consumer Trust with a focus on the German speaking market

Robert Gielow on Longevity Products, Pharmacy Access and Consumer Trust with a focus on the German speaking market

Daphna sat down with Robert Gielow, founder of Mentry Pharma, to discuss what it really takes for foreign supplement and longevity companies to enter the pharmacy markets of Germany, Austria and Switz...

5 Jul 1h

AI, Ageing And The Question Of Trust with Dr Filippo Dall'Armellina

AI, Ageing And The Question Of Trust with Dr Filippo Dall'Armellina

Biology is undergoing one of the biggest transformations in its history. AI is helping researchers analyse enormous datasets, predict protein structures, identify drug targets, and accelerate scientif...

28 Jun 57min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
romkapsel
rss-nysgjerrige-norge
liberal-halvtime
rekommandert
jss
villmarksliv
dekodet-2
abels-tarn
sinnsyn
vett-og-vitenskap-med-gaute-einevoll
fjellsportpodden
rss-overskuddsliv
rss-rekommandert
rss-paradigmepodden
tomprat-med-gunnar-tjomlid
diagnose
rss-inn-til-kjernen-med-sunniva-rose
nordnorsk-historie